Dudley & Shanley Inc. boosted its position in Amdocs Limited (NASDAQ:DOX - Free Report) by 7.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 261,826 shares of the technology company's stock after purchasing an additional 18,600 shares during the quarter. Amdocs comprises 3.6% of Dudley & Shanley Inc.'s investment portfolio, making the stock its 15th biggest position. Dudley & Shanley Inc. owned about 0.23% of Amdocs worth $22,905,000 at the end of the most recent reporting period.
Several other large investors have also recently bought and sold shares of the company. Principal Financial Group Inc. increased its holdings in shares of Amdocs by 6.6% in the 3rd quarter. Principal Financial Group Inc. now owns 1,032,867 shares of the technology company's stock worth $90,355,000 after buying an additional 63,718 shares during the last quarter. Franklin Resources Inc. boosted its holdings in shares of Amdocs by 71.6% in the 3rd quarter. Franklin Resources Inc. now owns 152,230 shares of the technology company's stock worth $13,580,000 after purchasing an additional 63,527 shares in the last quarter. Tidal Investments LLC raised its holdings in shares of Amdocs by 2.6% during the 3rd quarter. Tidal Investments LLC now owns 113,671 shares of the technology company's stock valued at $9,944,000 after buying an additional 2,885 shares in the last quarter. Wilmington Savings Fund Society FSB bought a new stake in Amdocs in the 3rd quarter worth approximately $130,000. Finally, Rehmann Capital Advisory Group raised its stake in shares of Amdocs by 7.7% during the third quarter. Rehmann Capital Advisory Group now owns 15,949 shares of the technology company's stock worth $1,411,000 after acquiring an additional 1,136 shares in the last quarter. 92.02% of the stock is owned by institutional investors.
Amdocs Stock Performance
Amdocs stock traded down $0.47 during mid-day trading on Monday, reaching $86.54. 675,607 shares of the stock traded hands, compared to its average volume of 684,228. The stock has a market capitalization of $9.77 billion, a PE ratio of 20.41, a price-to-earnings-growth ratio of 1.45 and a beta of 0.72. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.24. The business's 50-day moving average is $87.87 and its 200-day moving average is $84.93. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04.
Amdocs Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.479 per share. This represents a $1.92 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Tuesday, December 31st. Amdocs's dividend payout ratio is presently 45.05%.
Analyst Ratings Changes
DOX has been the topic of a number of research analyst reports. Barclays reduced their price target on Amdocs from $113.00 to $111.00 and set an "overweight" rating on the stock in a report on Thursday, November 14th. Stifel Nicolaus began coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They set a "buy" rating and a $100.00 price objective on the stock. Oppenheimer raised their target price on shares of Amdocs from $98.00 to $105.00 and gave the stock an "outperform" rating in a research report on Wednesday, November 13th. Finally, StockNews.com cut shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research report on Thursday, November 14th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $101.20.
Read Our Latest Stock Analysis on Amdocs
Amdocs Company Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
See Also
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.